Evidence map›Paper›PMID 40212674›Full record

ArticleSmall science2022

Driving Forces Sorted In Situ Size-Increasing Strategy for Enhanced Tumor Imaging and Therapy.

Yue Wang, Wenyao Zhen, Xiue Jiang, Jinghong Li

Abstract read
In one paragraph

Article in Small science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yue WangState Key Laboratory of Electroanalytical Chemistry Changchun Institute of Applied Chemistry Chinese Academy of Sciences Changchun Jilin 130022 China.
Wenyao ZhenState Key Laboratory of Electroanalytical Chemistry Changchun Institute of Applied Chemistry Chinese Academy of Sciences Changchun Jilin 130022 China.
Xiue JiangState Key Laboratory of Electroanalytical Chemistry Changchun Institute of Applied Chemistry Chinese Academy of Sciences Changchun Jilin 130022 China.
Jinghong LiDepartment of Chemistry Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology Tsinghua University Beijing 100084 China.ORCID 0000-0002-0750-7352

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanoparticles (NPs) with diverse functionalities are widely used in tumor diagnostic and therapeutic. However, the therapeutic efficiency is unsatisfactory because of the limited penetration depth as well as short retention time in a solid tumor, resulting in the inaccessibility of NPs and low tumor treatment efficiency. Therefore, it is of extreme vital significance to design NPs for simultaneously realizing deep penetration and long retention. Considering that the smaller-sized NPs may penetrate deeply in tumor and large-sized NPs show enhanced retention, many kinds of in situ size-increasing strategies of NPs have recently been developed for precise tumor imaging and therapy. In this review, the recent progress of stimuli-induced size increasing of NPs in vivo according to the driving forces inducing the aggregation of the smaller entity into bigger one with ordered or unordered structures in disease sites is summarized. The biomedical applications of the size-increasing strategy in the field of tumor imaging and therapeutics are introduced. Finally, the potential challenges underlying this strategy are briefly listed and its possible future clinical transformation directions are envisioned.

Indexed as

self-aggregationself-assembly of small moleculestumor imagingtumor therapy

Identifiers

PMID40212674
PMCPMC11936034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.